Effect of mushrooms on obesity in animal models: study protocol for a systematic review and meta-analysis

Denise Grotto1, Isabella Ferreira Camargo2, Katia Kodaira2

  • 1Pharmaceutical Sciences Graduate Course, University of Sorocaba, Rodovia Raposo Tavares, Km 92.5, Sorocaba, SP, 18023-000, Brazil. denise.grotto@prof.uniso.br.

Systematic Reviews
|November 28, 2019
PubMed
Abstract

Insights

This systematic review examines mushroom efficacy for weight loss in animal models. It synthesizes preclinical data to clarify mushrooms

Area of Science:

  • Preclinical research
  • Obesity and metabolic disorders
  • Nutraceuticals and dietary interventions

Background:

  • Obesity is a global health epidemic requiring effective weight management strategies.
  • The impact of mushrooms on body weight remains uncertain, necessitating further investigation.
  • Edible and medicinal mushrooms are explored for potential health benefits, including weight modulation.

Purpose of the Study:

  • To systematically review and determine the efficacy of mushrooms in promoting weight loss in animal preclinical models.
  • To consolidate evidence from existing studies on mushroom consumption and its effects on body weight in mammals.
  • To identify research gaps and encourage future studies in this area.

Main Methods:

  • Systematic review of preclinical studies involving non-aquatic mammal models of obesity.
  • Oral administration of edible and medicinal mushrooms compared to control groups.
  • Data extraction and risk of bias assessment using established tools (SYRCLE, CAMARADES).
  • Meta-analysis of standardized mean differences (SMD) with 95% confidence intervals (CI) to quantify treatment effects.

Main Results:

  • Analysis of body weight changes as the primary outcome.
  • Evaluation of secondary outcomes including food consumption, metabolic parameters, and inflammatory markers.
  • Assessment of study limitations and strengths to guide future research directions.

Conclusions:

  • This review will provide evidence-based insights into the role of mushrooms in preclinical weight loss studies.
  • Findings will inform public health managers and governmental entities about the potential of mushroom-based interventions.
  • The study aims to clarify the current scientific consensus and stimulate further research into mushroom's effects on obesity.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.2K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
136
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
202